Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.

Palacios-Baena ZR, Delgado-Valverde M, Valiente Méndez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurguí M, De la Calle C, García-Álvarez L, Ramos L, Gozalo M, Morosini MI, Molina J, Causse M, Pascual Á, Rodríguez-Baño J; REIPI/GEIRAS-SEIMC Bacteraemia-MIC Group .

Clin Infect Dis. 2019 Aug 30;69(6):956-962. doi: 10.1093/cid/ciy1032.

PMID:
30535051
2.

MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae.

Delgado-Valverde M, Valiente-Mendez A, Torres E, Almirante B, Gómez-Zorrilla S, Borrell N, Aller-García AI, Gurgui M, Almela M, Sanz M, Bou G, Martínez-Martínez L, Cantón R, Antonio Lepe J, Causse M, Gutiérrez-Gutiérrez B, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group.

J Antimicrob Chemother. 2017 May 1;72(5):1478-1487. doi: 10.1093/jac/dkw562.

PMID:
28093484
3.

Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.

Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group.

J Antimicrob Chemother. 2016 Feb;71(2):521-30. doi: 10.1093/jac/dkv362. Epub 2015 Nov 3.

PMID:
26538507
4.

Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort study.

Len O, Rodríguez-Pardo D, Gavaldà J, Aguado JM, Blanes M, Borrell N, Bou G, Carratalà J, Cisneros JM, Fortún J, Gurguí M, Montejo M, Cervera C, Muñoz P, Asensio A, Torre-Cisneros J, Pahissa A; Spanish Research Network for the Study of Infection in Transplantation.

Transpl Int. 2012 Dec;25(12):1275-81. doi: 10.1111/j.1432-2277.2012.01568.x. Epub 2012 Oct 5.

5.

Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.

Vidal E, Torre-Cisneros J, Blanes M, Montejo M, Cervera C, Aguado JM, Len O, Carratalá J, Cordero E, Bou G, Muñoz P, Ramos A, Gurguí M, Borrell N, Fortún J; Spanish Network for Research in Infectious Diseases (REIPI).

Transpl Infect Dis. 2012 Dec;14(6):595-603. doi: 10.1111/j.1399-3062.2012.00744.x. Epub 2012 Jun 1.

PMID:
22650416
6.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group.

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
7.

Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.

Aguilar-Guisado M, Jiménez-Jambrina M, Espigado I, Rovira M, Martino R, Oriol A, Borrell N, Ruiz I, Martín-Dávila P, de la Cámara R, Salavert M, de la Torre J, Cisneros JM; Spanish Network for Research in Infectious Diseases.

Clin Transplant. 2011 Nov-Dec;25(6):E629-38. doi: 10.1111/j.1399-0012.2011.01495.x. Epub 2011 Aug 21.

PMID:
22150886
8.

Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.

Rodríguez-Baño J, Miró E, Villar M, Coelho A, Gozalo M, Borrell N, Bou G, Conejo MC, Pomar V, Aracil B, Larrosa N, Agüero J, Oliver A, Fernández A, Oteo J, Pascual A, Navarro F.

J Infect. 2012 Feb;64(2):176-83. doi: 10.1016/j.jinf.2011.11.016. Epub 2011 Nov 23.

PMID:
22138600
9.

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients.

Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A; Spanish Network for Research on Infection in Transplantation (RESITRA/REIPI). Spain.

Antivir Ther. 2011;16(7):951-7. doi: 10.3851/IMP1858.

PMID:
22024510
10.

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Pemán J, Cantón E, Linares-Sicilia MJ, Roselló EM, Borrell N, Ruiz-Pérez-de-Pipaon MT, Guinea J, García J, Porras A, García-Tapia AM, Pérez-Del-Molino L, Suárez A, Alcoba J, García-García I.

J Clin Microbiol. 2011 Dec;49(12):4158-63. doi: 10.1128/JCM.05474-11. Epub 2011 Oct 19.

11.

Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort.

Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Muñoz P, Ramos A, Gurgui M, Borrell N, Fortún J, Moreno A, Gavalda J; Spanish Network for Research in Infectious Diseases.

Clin Infect Dis. 2009 Jun 15;48(12):1657-65. doi: 10.1086/599035.

PMID:
19445585
12.

Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection.

Rodríguez-Rojas A, Mena A, Martín S, Borrell N, Oliver A, Blázquez J.

Microbiology. 2009 Apr;155(Pt 4):1050-7. doi: 10.1099/mic.0.024745-0.

PMID:
19332807
13.

Donor infection and transmission to the recipient of a solid allograft.

Len O, Gavaldà J, Blanes M, Montejo M, San Juan R, Moreno A, Carratalà J, de la Torre-Cisneros J, Bou G, Cordero E, Muñoz P, Cuervas-Mons V, Alvarez MT, Borrell N, Fortun J, Pahissa A; Spanish Research Network for the Study of Infection in Transplantation.

Am J Transplant. 2008 Nov;8(11):2420-5. doi: 10.1111/j.1600-6143.2008.02397.x.

14.

Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.

Len O, Gavaldà J, Aguado JM, Borrell N, Cervera C, Cisneros JM, Cuervas-Mons V, Gurguí M, Martin-Dávila P, Montejo M, Muñoz P, Bou G, Carratalà J, Torre-Cisneros J, Pahissa A; RESITRA.

Clin Infect Dis. 2008 Jan 1;46(1):20-7. doi: 10.1086/523590.

PMID:
18171208
15.

Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation.

Mulcahy H, O'Callaghan J, O'Grady EP, Maciá MD, Borrell N, Gómez C, Casey PG, Hill C, Adams C, Gahan CG, Oliver A, O'Gara F.

Infect Immun. 2008 Feb;76(2):632-8. Epub 2007 Nov 19.

16.

Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.

Maciá MD, Mena A, Borrell N, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2007 Dec;51(12):4531-2. Epub 2007 Sep 24. No abstract available.

17.

Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

Plasencia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2007 Jul;51(7):2574-81. Epub 2007 Apr 30.

18.

Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice.

Mena A, Maciá MD, Borrell N, Moya B, de Francisco T, Pérez JL, Oliver A.

J Bacteriol. 2007 May;189(9):3665-8. Epub 2007 Feb 16.

19.

Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.

Mena A, Plasencia V, García L, Hidalgo O, Ayestarán JI, Alberti S, Borrell N, Pérez JL, Oliver A.

J Clin Microbiol. 2006 Aug;44(8):2831-7.

20.

Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.

Padilla E, Alonso D, Doménech-Sánchez A, Gomez C, Pérez JL, Albertí S, Borrell N.

Antimicrob Agents Chemother. 2006 Jun;50(6):2258-60.

21.

Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.

Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2006 Mar;50(3):975-83.

22.

Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.

Juan C, Gutiérrez O, Oliver A, Ayestarán JI, Borrell N, Pérez JL.

Clin Microbiol Infect. 2005 Nov;11(11):887-92.

23.

Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion.

Maciá MD, Borrell N, Pérez JL, Oliver A.

Antimicrob Agents Chemother. 2004 Jul;48(7):2665-72.

24.

Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain.

Alcalá B, Arreaza L, Salcedo C, Antolín I, Borrell N, Cacho J, De Las Cuevas C, Otero L, Sauca G, Vázquez F, Villar H, Vázquez JA.

Sex Transm Dis. 2003 May;30(5):395-8.

PMID:
12916129
25.
26.

Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.

López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.

Antimicrob Agents Chemother. 2001 May;45(5):1387-93.

27.

Typing of clinical and environmental Aeromonas veronii strains based on the 16S-23S rDNA spacers.

Martínez-Murcia AJ, Borrell N, Figueras MJ.

FEMS Immunol Med Microbiol. 2000 Jul;28(3):225-32.

28.

Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Gavaldà J, Torres C, Tenorio C, López P, Zaragoza M, Capdevila JA, Almirante B, Ruiz F, Borrell N, Gomis X, Pigrau C, Baquero F, Pahissa A.

Antimicrob Agents Chemother. 1999 Mar;43(3):639-46.

29.
30.

Phenotypic identification of Aeromonas genomospecies from clinical and environmental sources.

Borrell N, Figueras MJ, Guarro J.

Can J Microbiol. 1998 Feb;44(2):103-8.

PMID:
9575026
31.

Identification of Aeromonas clinical isolates by restriction fragment length polymorphism of PCR-amplified 16S rRNA genes.

Borrell N, Acinas SG, Figueras MJ, Martínez-Murcia AJ.

J Clin Microbiol. 1997 Jul;35(7):1671-4.

32.

[Clinical and microbiologic characteristics of 282 pediatric patients with mesophilic Aeromonas isolated from feces].

Reina J, Hervás J, Serra A, Borrell N.

Enferm Infecc Microbiol Clin. 1993 Aug-Sep;11(7):366-72. Spanish.

PMID:
8399474
33.

Acute gastroenteritis caused by Hafnia alvei in children.

Reina J, Hervas J, Borrell N.

Clin Infect Dis. 1993 Mar;16(3):443. No abstract available.

PMID:
8452958
34.

[Efficacy of cefsulodin -irgasan-novobiocin agar media in the isolation of Aeromonas mesophiles from feces].

Reina J, Serra A, Borrell N.

Enferm Infecc Microbiol Clin. 1993 Feb;11(2):114-6. Spanish. No abstract available.

PMID:
8481436
35.

Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.

Reina J, Borrell N, Serra A.

Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1163-6.

PMID:
1291314
36.

[The suicide phenomenon and fermentative metabolic activity in strains of the Aeromonas group isolated from feces].

Reina J, Serra A, Borrell N, Gómez J.

Enferm Infecc Microbiol Clin. 1992 Nov;10(9):536-8. Spanish.

PMID:
1489794
37.

Community-acquired bacteremia caused by Serratia plymuthica. Case report and review of the literature.

Reina J, Borrell N, Llompart I.

Diagn Microbiol Infect Dis. 1992 Jul;15(5):449-52.

PMID:
1643822
38.

Rectal bleeding caused by Campylobacter jejuni in a neonate.

Reina J, Borrell N, Fiol M.

Pediatr Infect Dis J. 1992 Jun;11(6):500-1. No abstract available.

PMID:
1608692
39.

Leg abscess caused by Weeksella zoohelcum following a dog bite.

Reina J, Borrell N.

Clin Infect Dis. 1992 May;14(5):1162-3. No abstract available.

PMID:
1600024
40.
41.

Sphingobacterium multivorum isolated from a patient with cystic fibrosis.

Reina J, Borrell N, Figuerola J.

Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):81-2. No abstract available.

PMID:
1563393
42.

Infections with Pseudomonas paucimobilis: report of four cases and review.

Reina J, Bassa A, Llompart I, Portela D, Borrell N.

Rev Infect Dis. 1991 Nov-Dec;13(6):1072-6. Review.

PMID:
1775840
43.

[Assignment of strains of the mesophilic Aeromonas group isolated from feces to their corresponding hybridization groups (genus, species)].

Reina J, Llompart I, Gómez J, Borrell N, Serra A.

Enferm Infecc Microbiol Clin. 1991 Aug-Sep;9(7):440-1. Spanish. No abstract available.

PMID:
1799619
44.

[Detection of strains of E. coli producing STa toxin in the feces of patients with diarrhea using a competitive ELISA system].

Reina J, Gómez J, Llompart I, Borrell N, Serra A.

Enferm Infecc Microbiol Clin. 1991 Apr;9(4):223-5. Spanish.

PMID:
1863622
45.

[Infection of a neoplastic ovarian cyst caused by Salmonella enterica subspecies enterica, serotype Enteritidis].

Reina J, Borrell N.

Enferm Infecc Microbiol Clin. 1991 Mar;9(3):185-6. Spanish. No abstract available.

PMID:
1863613
46.

Pneumonia caused by Bordetella bronchiseptica in a patient with a thoracic trauma.

Reina J, Bassa A, Llompart I, Borrell N, Gomez J, Serra A.

Infection. 1991 Jan-Feb;19(1):46-8.

PMID:
2013509
47.

Analysis of the autoagglutination phenomenon, serogroup and hydrophobicity as virulence markers in mesophilic aeromonads isolated from stool cultures.

Reina J, Llompart I, Gomez J, Borrell N, Serra A, Alomar P.

Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):897-901.

PMID:
2073902

Supplemental Content

Loading ...
Support Center